KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Receivables - Net: 2010-2023

Historic Receivables - Net for Nektar Therapeutics (NKTR) over the last 14 years, with Dec 2023 value amounting to $1.2 million.

  • Nektar Therapeutics' Receivables - Net was N/A to $200,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $200,000, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2023, which is 79.85% down from last year.
  • Per Nektar Therapeutics' latest filing, its Receivables - Net stood at $1.2 million for FY2023, which was down 79.85% from $6.0 million recorded in FY2022.
  • In the past 5 years, Nektar Therapeutics' Receivables - Net registered a high of $38.9 million during FY2020, and its lowest value of $1.2 million during FY2023.
  • Over the past 3 years, Nektar Therapeutics' median Receivables - Net value was $6.0 million (recorded in 2022), while the average stood at $9.9 million.
  • In the last 5 years, Nektar Therapeutics' Receivables - Net climbed by 5.67% in 2020 and then slumped by 79.85% in 2023.
  • Over the past 5 years, Nektar Therapeutics' Receivables - Net (Yearly) stood at $36.8 million in 2019, then rose by 5.67% to $38.9 million in 2020, then slumped by 42.16% to $22.5 million in 2021, then tumbled by 73.41% to $6.0 million in 2022, then plummeted by 79.85% to $1.2 million in 2023.